This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Autophagysciences Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Hyeongwan Choi: Innovator in Autophagy Research
Introduction
Hyeongwan Choi is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of autophagy regulation. His innovative work has the potential to impact the treatment of various diseases.
Latest Patents
Hyeongwan Choi holds a patent for a novel compound and pharmaceutical composition. The patent, titled "Compound and pharmaceutical composition comprising same," focuses on a compound that activates autophagy. This compound can be valuable in preventing or treating diseases associated with autophagy regulation. He has 1 patent to his name.
Career Highlights
Choi is currently associated with Autophagy Sciences Inc., where he continues to advance research in his field. His work is characterized by a commitment to understanding the mechanisms of autophagy and its implications for health.
Collaborations
Hyeongwan Choi collaborates with notable colleagues, including Jung Ju Kim and Seong-Won Song. Their combined expertise enhances the research efforts at Autophagy Sciences Inc.
Conclusion
Hyeongwan Choi's innovative contributions to autophagy research position him as a key figure in the pharmaceutical industry. His work holds promise for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile